Quest Laboratories
QUESTLAB · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
4.3%
1m
8.6%
3m
18.0%
6m
24.3%
1y
14.6%
all
16.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 82 0%
81.3
122
Company Overview

Sales
112 Cr
Growth: 42.0%
Profit after Tax
15 Cr
Growth: 6.6%
Micro Cap
134 Cr
P/E: 9.0x
Industry P/E: 34.2x
Fundamentals

Sales (Cr) ₹ 112
Growth 42.0%
EBITDA 16.3%
P/S 1.2x
Dividend 0.0%
P/E 9.0x
Book Value ₹ 10
PEG Ratio 0.2x
ROE 91.6%
P/B N/A
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is primarily engaged in the manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company also produces variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
Belongs to (1 Indices)